Gsk (GSK) Receivables - Net (2009 - 2026)
Gsk (GSK) posted quarterly Receivables - Net of $10.3 billion for Q2 2026, up 5.86% year-over-year from $9.8 billion in Q2 2025, and down 1.12% quarter-over-quarter from $10.5 billion in Q1 2026.
Gsk (GSK) Receivables - Net (2009 - 2026) Analysis & Trends
Gsk's Receivables - Net history runs 18 years deep, the most recent figure standing at $10.3 billion for Q2 2026.
- In Q2 2026, Receivables - Net rose 5.86% year-over-year to $10.3 billion; the TTM figure through Jun 2026 stood at $10.3 billion (up 5.86% YoY), while the FY2025 annual figure was $9.9 billion, up 12.73% from the prior year.
- Receivables - Net for Q2 2026 stood at $10.3 billion, down from $10.5 billion in the prior quarter.
- The five-year high for Receivables - Net was $10.8 billion in Q3 2023, with the low at $3.2 billion in Q1 2022.
- The 5-year median for Receivables - Net is $9.0 billion (2024), against an average of $9.0 billion.
- The sharpest annual moves came in 2022 and 2023: Receivables - Net tumbled 63.8% in 2022, then surged 156.3% in 2023.
- Gsk's Receivables - Net stood at $8.3 billion in 2022, then grew by 10.8% to $9.2 billion in 2023, then decreased by 4.28% to $8.8 billion in 2024, then advanced by 13.26% to $9.9 billion in 2025, then gained by 4.04% to $10.3 billion in 2026.
- Business Quant data shows GSK's Receivables - Net at $10.3 billion in Q2 2026, $10.5 billion in Q1 2026, and $9.9 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.15 Bn | 634.39 Bn | 17.26 Bn |
| 2 | AbbVie | 469.47 Bn | 462.91 Bn | 12.70 Bn |
| 3 | Merck | 380.63 Bn | 373.49 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.58 Bn | 294.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.84 Bn | 252.94 Bn | 12.86 Bn |
| 6 | Amgen | 236.70 Bn | 222.71 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.92 Bn | 179.74 Bn | 6.22 Bn |
| 8 | Pfizer | 161.16 Bn | 149.47 Bn | 10.94 Bn |
| 9 | Gsk | 105.59 Bn | 101.42 Bn | 8.24 Bn |
| 10 | Sanofi | 54.99 Bn | 47.61 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.34 Bn |
| Jun 30, 2026 | 10.34 Bn |
| Mar 31, 2026 | 10.46 Bn |
| Mar 31, 2026 | 10.46 Bn |
| Dec 31, 2025 | 9.94 Bn |
| Dec 31, 2025 | 9.94 Bn |
| Sep 30, 2025 | 10.71 Bn |
| Sep 30, 2025 | 10.71 Bn |
| Jun 30, 2025 | 9.77 Bn |
| Jun 30, 2025 | 9.77 Bn |
| Mar 31, 2025 | 8.89 Bn |
| Mar 31, 2025 | 8.89 Bn |
| Dec 31, 2024 | 8.77 Bn |
| Dec 31, 2024 | 8.77 Bn |
| Sep 30, 2024 | 9.59 Bn |
| Sep 30, 2024 | 9.59 Bn |
| Jun 30, 2024 | 9.16 Bn |
| Jun 30, 2024 | 9.16 Bn |
| Mar 31, 2024 | 8.67 Bn |
| Mar 31, 2024 | 8.67 Bn |